Principal Investigator
Enrollment Status
Clinical Trial ID
Clinical Trial Summary
This study is an access and distribution protocol for unlicensed cryopreserved cord blood
units (CBUs) in pediatric and adult patients with hematologic malignancies and other
indications.
Phase
Phase IV
Funding Agency/Sponsor
Industrial
Disease
Pediatric Cancer
Enrollment Eligibility
Inclusion Criteria:
- Disorders affecting the hematopoietic system that are inherited, acquired, or result
from myeloablative treatment
- Signed informed consent (and signed assent, if applicable) obtained prior to study
enrollment
- Pediatric and adult patients of any age
Exclusion Criteria:
- Patients who are receiving only licensed CBUs
- Cord blood transplant recipients at international transplant centers
- Patients who are enrolled on another IND protocol to access the unlicensed CBU(s)
- Patients whose selected unlicensed CBU(s) will be more than minimally manipulated